20 October 2020PatentsMuireann Bolger

LSPN Connect: will nationalism block access to a COVID-19 vaccine?

As scientists around the globe race to find a vaccine for COVID-19, the big question for many is whether competition between nation-states will interfere with citizens’ access to these life-saving treatments.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

LSPN Connect: The Tech Access Partnership and COVID-19

1 July 2020 COVID-19 poses challenges for the whole world, but there is a risk that the least-developed countries are left behind in the race for technology to fight it.

Patents

Biden backs TRIPS waiver for COVID-19 vaccines

6 May 2021 President Joe Biden has backed the waiving of IP rights for COVID-19 vaccines following mounting pressure from countries, charities and industry bodies.

Patents

US backs COVID IP waiver - Industry reacts

7 May 2021 After months of open letters and petitions from various sources, the US government has decided to throw its support behind waiving IP rights for COVID-19 vaccines.

On our radar...

Philip Morris case triggers AIPPI call for EPO action

UK firms Venner Shipley and AA Thornton combine

UPC docs 'excessively redacted' under GDPR claims transparency lawyer

L'Oréal sued over virtual makeup try-on simulator

Kathi Vidal to leave USPTO ahead of incoming Trump administration

Q&A: EagleView counsel maps out route to IPR victory

WIPO in Saudi Arabia to finalise design law treaty

LSPN Connect: will nationalism block access to a COVID-19 vaccine?

More on this story

Editor's picks

Editor's picks

More articles